Table 2.

Clinical data in the placebo versus albuterol groups

	Placebo (N = 246)	Albuterol (N = 260)	P value
Time from enrollment to organ procurement (h)	42 ± 15	38 ± 14	0.002
Baseline to final ABG time (h)	37 ± 16	33 ± 14	0.002
Doses of study drug received	9 ± 3	8 ± 3	<0.001
Percent of expected doses eceived	86%	87%	0.41
Open label albuterol	15 (6%)	11 (4%)	0.34
Donors with dose reduction for tachycardia	3 (1%)	35 (13%)	<0.001
Donors with study drug stopped for tachycardia	0 (0%)	21 (8%)	<0.001

Data as mean ± SD or N (%)